ACTH releasing activity of KP-102 in rats is mainly mediated via release of CRF

被引：0
|
作者：
Hirotani, C
Oki, Y
Ukai, K
Kurasaki, S
Doi, N
机构：
[1] Kaken Pharm Co Ltd, Cent Res Labs, Kyoto 6078042, Japan
[2] Hamamatsu Univ Sch Med, Dept Med 2, Hamamatsu, Shizuoka 4313192, Japan
[3] Kaken Pharm Co Ltd, Tokyo 1138650, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2005年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：287P / 287P
页数：1
相关论文
共 50 条
  • [1] ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF
    Hirotani, C
    Oki, Y
    Ukai, K
    Okuno, T
    Kurasaki, S
    Ohyama, T
    Doi, N
    Sasaki, K
    Ase, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 (01) : 54 - 60
  • [2] ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF
    Chiharu Hirotani
    Yutaka Oki
    Kiyoharu Ukai
    Tadashi Okuno
    Shigeru Kurasaki
    Tadashi Ohyama
    Naomi Doi
    Ken Sasaki
    Katsuhiko Ase
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2005, 371 : 54 - 60
  • [3] Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102, KP-102 LN, KP-102D, KP-102LN
    不详
    Drugs in R & D, 2004, 5 (4) : 236 - 239
  • [4] Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats
    Nakagawa, T
    Ukai, K
    Ohyama, T
    Koida, M
    Okamura, H
    LIFE SCIENCES, 1996, 59 (09) : 705 - 712
  • [5] Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats
    Okada, K
    Ishii, S
    Minami, S
    Sugihara, H
    Shibasaki, T
    Wakabayashi, I
    ENDOCRINOLOGY, 1996, 137 (11) : 5155 - 5158
  • [6] ELECTRICALLY STIMULATED ACTH RELEASE IN PHARMACOLOGICALLY BLOCKED RATS - SITE OF CRF RELEASING ELEMENTS
    DUNN, J
    CRITCHLO.V
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A222 - &
  • [7] Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide
    Doi, N
    Hirotani, C
    Ukai, K
    Shimada, O
    Okuno, T
    Kurasaki, S
    Kiyofuji, T
    Ikegami, R
    Futamata, M
    Nakagawa, T
    Ase, K
    Chihara, K
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (12): : 857 - 867
  • [8] General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide
    Furuta, S
    Shimada, O
    Doi, N
    Ukai, K
    Nakagawa, T
    Watanabe, J
    Imaizumi, M
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2004, 54 (12): : 868 - 880
  • [9] Cardioprotective effect of KP-102, a synthetic growth hormone-releasing peptide, in ischemia-reperfusion injury
    Ohyam, T
    Furuta, S
    Hori, T
    Ueo, H
    Shiraishi, N
    Amakawa, M
    Murata, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 229A - 230A
  • [10] The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus
    Kamegai, J
    Hasegawa, O
    Minami, S
    Sugihara, H
    Wakabayashi, I
    MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2): : 153 - 159
12345